An Unexpected Foe Challenges Pharma In Aussie Generics-For-Export Battle
This article was originally published in PharmAsia News
Executive Summary
Generic manufacturers and labor groups in Australia say current patent legislation is handicapping industry's ability to compete on the world stage and that, if the status quo remains, manufacturing and jobs are likely to go elsewhere
You may also be interested in...
Resisting Calls For More Freedom To Produce Generics For Export, Australia's IP Regime Is Safe For Now, But Generic Makers, Unions Ready For Battle
PERTH, Australia - An earlier proposal put forth to legislators by generics maker Hospira to ease restrictions on producing generics for export has been shot down
Resisting Calls For More Freedom To Produce Generics For Export, Australia's IP Regime Is Safe For Now, But Generic Makers, Unions Ready For Battle
PERTH, Australia - An earlier proposal put forth to legislators by generics maker Hospira to ease restrictions on producing generics for export has been shot down
Australian Legislators Debate Whether To Ease Restrictions On Producing Generic Drugs For Export
HONG KONG - The Australian government is mulling whether to allow local manufacturers to produce generic versions of drugs that are still under patent protection inside the country for export to markets in which patents have expired